# Abbreviated Protocol for Two-Stage Exchange

> **NCT04662632** · PHASE2 · COMPLETED · sponsor: **Osteal Therapeutics, Inc.** · enrollment: 76 (actual)

## Conditions studied

- Prosthetic Joint Infection

## Interventions

- **COMBINATION_PRODUCT:** VT-X7 Treatment System with Tobramycin Sulfate
- **DRUG:** Standard of Care
- **PROCEDURE:** Two-stage exchange arthroplasty
- **COMBINATION_PRODUCT:** VT-X7 Treatment System with Vancomycin Hydrochloride

## Key facts

- **NCT ID:** NCT04662632
- **Lead sponsor:** Osteal Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2023-03-13
- **Final completion:** 2023-12-22
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04662632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04662632, "Abbreviated Protocol for Two-Stage Exchange". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04662632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*